person · Reporting owner
WALSH CHRISTOPHER T PHD
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INCIRWD · Entity 5213 | Director | March 15, 2017 | March 16, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRONWOOD PHARMACEUTICALS INC
Report date March 15, 2017 · Filed March 16, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 71,499 |
Reported balance
After 2017-03-15 transaction · row 1
1 source rowRow 1 · 2017-03-15 · Grant · Acquired 142 · Balance 71,499 F1: Issued pursuant to the Director Compensation Plan, effective as of January 2014. |
| Class B Common StockSEC Table I · non-derivative | Direct | 303,026 |
Reported balance
Holding disclosure · report date 2017-03-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 303,026 |
Filing footnotes · ownership attribution and instrument terms
F1: Issued pursuant to the Director Compensation Plan, effective as of January 2014.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2017 Filed Mar 16, 2017 17:10 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 142 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021133 · doc4.xml · nonDerivative · entry 1 WALSH CHRISTOPHER T PHD · CIK 0001120360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,499 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 17:39 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 161 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155979 · doc4.xml · nonDerivative · entry 1 WALSH CHRISTOPHER T PHD · CIK 0001120360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,357 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 16:42 UTC | IRONWOOD PHARMACEUTICALS INC IRWD · Entity 5213 | GrantClass A Common Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-141989 · doc4.xml · nonDerivative · entry 1 WALSH CHRISTOPHER T PHD · CIK 0001120360 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,196 F1 · kind: Issued pursuant to the Director Compensation Plan, effective as of January 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.